PHVS · Insider trading · 13F holders · Congress trades
Pharvaris N.V. (PHVS)
Who is buying and selling PHVS: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 32
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $20.4M
- Congress trades, 12 months
- 0
PHVS at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 10 PHVS insiders filed 17 sales worth $20.4M on SEC Form 4, and no open-market purchases; 9 of the sales were pre-planned under Rule 10b5-1.
- 32 13F filers hold PHVS among their 50 largest positions, worth $1.4B combined, including James Flynn and Oleg Nodelman. The biggest bets by portfolio weight are 5AM Venture Management, LLC (9.6%), General Atlantic, L.P. (7.8%) and Saturn V Capital Management LP (6.5%). In their latest 13Fs, 3 managers opened a new position and 11 added to one.
- No member of Congress has disclosed a trade in PHVS.
- PHVS last closed at $33.58 on Oct 29, 2026.
PHVS insider trading
Between Aug 1, 2026 and Oct 29, 2026, 10 PHVS insiders filed 17 sales worth $20.4M on SEC Form 4, and no open-market purchases; 9 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Monges Viviane | Director | Sale | 11,969 | $33.05 | $396K | SEC |
| Sep 24, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sale | 800 | $36.19 | $29K | SEC |
| Sep 23, 2026 | Nassif David W. | CFO / CLO | Sale | 6,000 | $36.47 | $219K | SEC |
| Sep 21, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sale | 200,000 | $35.00 | $7.0M | SEC |
| Sep 21, 2026 | Lu Peng | President | Sale | 100,000 | $35.00 | $3.5M | SEC |
| Sep 21, 2026 | Bjork Elisabeth | Director | Sale | 52,500 | $37.89 | $2.0M | SEC |
| Sep 21, 2026 | Lesage Anne | Chief Early Development | Sale | 20,000 | $38.27 | $765K | SEC |
| Sep 21, 2026 | Glassman Robert | Director | Sale10b5-1 | 14,493 | $38.56 | $559K | SEC |
| Sep 17, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Sale | 46,400 | $38.17 | $1.8M | SEC |
| Sep 17, 2026 | Glassman Robert | Director | Sale10b5-1 | 8,667 | $38.27 | $332K | SEC |
| Sep 16, 2026 | Souverijns Wim | Chief Commercial Officer | Sale10b5-1 | 26,090 | $39.23 | $1.0M | SEC |
| Sep 15, 2026 | Lu Peng | President | Sale10b5-1 | 15,000 | $40.13 | $602K | SEC |
| Sep 15, 2026 | Modig Berndt | Chief Executive Officer, Director | Sale10b5-1 | 2,291 | $39.40 | $90K | SEC |
| Sep 14, 2026 | Lesage Anne | Chief Early Development | Sale10b5-1 | 30,000 | $38.30 | $1.1M | SEC |
| Sep 11, 2026 | Glassman Robert | Director | Sale10b5-1 | 8,000 | $37.55 | $300K | SEC |
| Sep 9, 2026 | Lu Peng | President | Sale10b5-1 | 15,000 | $40.68 | $610K | SEC |
| Aug 18, 2026 | Modig Berndt | Chief Executive Officer, Director | Sale10b5-1 | 2,292 | $34.77 | $80K | SEC |
Who owns PHVS? Hedge funds and superinvestors
32 13F filers hold PHVS among their 50 largest positions, worth $1.4B combined, including James Flynn and Oleg Nodelman. The biggest bets by portfolio weight are 5AM Venture Management, LLC (9.6%), General Atlantic, L.P. (7.8%) and Saturn V Capital Management LP (6.5%). In their latest 13Fs, 3 managers opened a new position and 11 added to one.
Superinvestors holding PHVS: James Flynn 1.5% · Oleg Nodelman 0.4%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| General Atlantic, L.P.Hedge fund | 7.8% | $226.5M | 6,550,757 | -18.4% shares | Q2 2026 |
| Foresite Capital Management IV, LLCHedge fund | 57.0% | $165.2M | 4,778,581 | +0.0% shares | Q2 2026 |
| venBio Partners LLCHedge fund | 30.9% | $160.6M | 4,643,430 | +0.1% shares | Q2 2026 |
| EQT Fund Management S.a r.l.Hedge fund | 13.7% | $118.4M | 3,424,609 | +0.0% shares | Q2 2026 |
| James FlynnHedge fund | 1.5% | $116.7M | 3,376,042 | +8.0% shares | Q2 2026 |
| Bain Capital Life Sciences Investors, LLCAsset manager | 5.5% | $92.5M | 2,675,509 | +0.0% shares | Q2 2026 |
| Commodore Capital LPHedge fund | 2.9% | $49.3M | 1,425,000 | -25.7% shares | Q2 2026 |
| Novo Holdings A/sInvestment manager | 2.8% | $48.4M | 1,400,000 | -20.0% shares | Q2 2026 |
| Saturn V Capital Management LPHedge fund | 6.5% | $45.4M | 1,314,122 | +9.4% shares | Q2 2026 |
| TCG Crossover Management, LLCHedge fund | 0.8% | $34.9M | 1,008,229 | New | Q2 2026 |
| Sofinnova Investments, Inc.Hedge fund | 1.6% | $30.5M | 881,299 | +7.7% shares | Q2 2026 |
| 5AM Venture Management, LLCVenture capital | 9.6% | $27.6M | 797,600 | +0.0% shares | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 4.4% | $26.8M | 774,501 | +348.4% shares | Q2 2026 |
| Cormorant Asset Management, LPHedge fund | 1.3% | $25.9M | 750,000 | -25.0% shares | Q2 2026 |
| Soleus Capital Management, L.P.Hedge fund | 0.9% | $25.3M | 730,907 | +4.1% shares | Q2 2026 |
| Jones Hill Capital LPHedge fund | 5.0% | $23.4M | 677,879 | +305.9% shares | Q2 2026 |
| Patient Square Capital LPHedge fund | 3.6% | $23.2M | 671,209 | +36.1% shares | Q2 2026 |
| Foresite Capital Management V, LLCHedge fund | 6.3% | $23.0M | 664,142 | +242.1% shares | Q2 2026 |
| Kynam Capital Management, LPHedge fund | 1.3% | $22.9M | 661,795 | +3.3% shares | Q2 2026 |
| Rock Springs Capital Management LPHedge fund | 1.1% | $22.4M | 648,333 | +0.4% shares | Q2 2026 |
| Elmind Capital, LPHedge fund | 4.6% | $18.2M | 525,750 | +10.5% shares | Q2 2026 |
| Dv Equities, LLCInvestment manager | 2.4% | $16.7M | 482,524 | — | Q2 2026 |
| Octagon Capital Advisors LPHedge fund | 1.4% | $15.8M | 456,721 | +176.8% shares | Q2 2026 |
| Eversept Partners, LPHedge fund | 0.7% | $13.4M | 386,383 | -5.1% shares | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 1.7% | $10.7M | 308,856 | -36.6% shares | Q2 2026 |
| Tetragon Partners GP LtdHedge fund | 1.7% | $10.2M | 295,627 | +33.4% shares | Q2 2026 |
| Oleg NodelmanHedge fund | 0.4% | $8.1M | 235,000 | New | Q2 2026 |
| Kalehua Capital Management LLCHedge fund | 4.9% | $6.9M | 198,772 | +0.0% shares | Q2 2026 |
| HighVista Strategies LLCHedge fund | 1.3% | $5.5M | 160,494 | +64.0% shares | Q2 2026 |
| NEXTBio Capital Management LPHedge fund | 1.7% | $3.7M | 108,055 | New | Q2 2026 |
The 30 largest of 32 positions, by value. Each manager counts with its latest 13F (Q2 2026: 32). Screen PHVS in the grand portfolio →
PHVS stock trades by members of Congress
No member of Congress has disclosed a trade in PHVS.
Analysis mentioning PHVS
Posts from the blog that cover Pharvaris N.V., newest first.
PHVS questions and answers
Are insiders buying PHVS stock?
Between Aug 1, 2026 and Oct 29, 2026, 10 PHVS insiders filed 17 sales worth $20.4M on SEC Form 4, and no open-market purchases; 9 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own PHVS?
32 13F filers hold PHVS among their 50 largest positions, worth $1.4B combined, including James Flynn and Oleg Nodelman. The biggest bets by portfolio weight are 5AM Venture Management, LLC (9.6%), General Atlantic, L.P. (7.8%) and Saturn V Capital Management LP (6.5%). In their latest 13Fs, 3 managers opened a new position and 11 added to one.
Has Congress traded PHVS?
No member of Congress has disclosed a trade in PHVS.
Who is the largest holder of PHVS?
Among 13F filers, General Atlantic, L.P. reports the largest PHVS position, $226.5M (6,550,757 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is 5AM Venture Management, LLC's: 9.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.